Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy
Purpose Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimate...
Saved in:
Published in | International urology and nephrology Vol. 50; no. 4; pp. 715 - 723 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.04.2018
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0301-1623 1573-2584 1573-2584 |
DOI | 10.1007/s11255-018-1812-2 |
Cover
Abstract | Purpose
Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease.
Methods
A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography–tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated.
Results
The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene–gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes.
Conclusions
By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals. |
---|---|
AbstractList | Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease.PURPOSESince altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease.A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography-tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated.METHODSA total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography-tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated.The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene-gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes.RESULTSThe Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene-gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes.By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals.CONCLUSIONSBy uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals. PurposeSince altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease.MethodsA total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography–tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated.ResultsThe Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene–gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes.ConclusionsBy uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals. Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease. A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography-tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated. The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene-gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes. By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals. Purpose Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect of polymorphic Arg16Gly and Gln27Glu in the β2 adrenoceptor gene and Ala54Thr in the fatty acid binding protein 2 gene on the estimated glomerular filtration rate (eGFR) in Chinese patients with the above disease. Methods A total of 552 diabetic subjects recruited from annual health examinations were studied. The eGFR was calculated from the Modification of Diet in Renal Disease equation for the Chinese. Plasma norepinephrine level and genotype were determined by high-performance liquid chromatography–tandem mass spectrometry and TaqMan method, respectively. Holter-derived heart rate viability (HRV) and the MRI-generated renal apparent diffusion coefficient (ADC) were evaluated. Results The Gly16Gly and Thr54Thr homozygotes had significantly higher microalbuminuria and lower eGFR against other genotypes in their individual polymorphism. Besides, the Gly16Gly variant exhibited markedly elevated norepinephrine level, whereas indicative of insulin resistance was increased in the Thr54Thr one. Multiple linear regression analysis further confirmed the independent genetic effect on the eGFR. Moreover, multifactor dimensionality reduction method detected a gene–gene synergistic action that subjects with the Gly16Gly/Thr54Thr genotype were exposed to higher risk of eGFR loss. Finally, these findings were accompanied by lower HRV and ADC, indicating sympathetically mediated hemodynamic changes. Conclusions By uncovering the genetic component of the coherent interplay between the elevated sympathetic nerve activity and metabolic disorders, our observations might promote the development of novel personalized prevention and management strategies against the diabetic nephropathy, especially in the genetically susceptible individuals. |
Author | Liu, Bing Wang, Ning Liu, Qiong Niu, Kai Wang, Tao Zhang, Yan Wang, ZeKai |
Author_xml | – sequence: 1 givenname: Tao orcidid: 0000-0002-7370-7299 surname: Wang fullname: Wang, Tao email: nephrology2009@hotmail.com organization: Department of Nephrology, HeBei General Hospital – sequence: 2 givenname: Yan surname: Zhang fullname: Zhang, Yan organization: Department of Dermatology, The 4th Affiliated Hospital of HeBei Medical University – sequence: 3 givenname: Ning surname: Wang fullname: Wang, Ning organization: Department of Radiology, The 4th Affiliated Hospital of HeBei Medical University – sequence: 4 givenname: Qiong surname: Liu fullname: Liu, Qiong organization: Department of Nephrology, HeBei General Hospital – sequence: 5 givenname: ZeKai surname: Wang fullname: Wang, ZeKai organization: Department of Nephrology, HeBei General Hospital – sequence: 6 givenname: Bing surname: Liu fullname: Liu, Bing organization: Department of Nephrology, HeBei General Hospital – sequence: 7 givenname: Kai surname: Niu fullname: Niu, Kai organization: Department of Nephrology, HeBei General Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29404926$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcGK1TAYhYOMOHdGH8CNBNy4qSZp0zRLuegoDLhQ1yE3_XubIU1qkiJ9LZc-hM806dwZkAFd_SR85-TkPxfozAcPCL2k5C0lRLxLlDLOK0K7inaUVewJ2lEu6orxrjlDO1ITWtGW1efoIqUbQojsCHmGzplsSCNZu0O_v64e4tGmbI12WJtsg8dhwHkE_OcXw7qP4IOBOYeIte_xoHNeC2h7fLC-t_6I5xgyWI8ZnoNbpxDn0aYp4eK02biQ0mZ5dGGCuDgd8WBdjvrurTIAF_F-tB4S4Llcg88J_7R5xHmdofj2Vh-gRMQe5jGGwozrc_R00C7Bi_t5ib5__PBt_6m6_nL1ef_-ujKsE6wSXHdtAxRkaxrREqlB6g6IaQ0YZvoWysmITgyN0BwolbpnpgUpqODDoa8v0ZuTb_nmjwVSVpNNBpzTHsKSFJWSU85ZVxf09SP0JizRl3Qb1TAimWgL9eqeWg4T9GqOdtJxVQ-tFECcABPL6iIMyth8t62yNOsUJWrrX536V6V_tfWvWFHSR8oH8_9p2EmTCuuPEP8K_U_RLXfcxiA |
CitedBy_id | crossref_primary_10_3389_fmed_2024_1444719 crossref_primary_10_1111_nep_13544 crossref_primary_10_3389_fgene_2019_00507 crossref_primary_10_1155_2022_5700249 |
Cites_doi | 10.1016/j.semnephrol.2012.07.003 10.2174/157339910790909396 10.1291/hypres.31.561 10.2337/diabetes.54.11.3326 10.1152/physiolgenomics.00070.2001 10.1007/s11906-003-0084-z 10.1016/0735-1097(88)90382-8 10.1152/physrev.00001.2010 10.1111/j.1440-1681.2008.04990.x 10.1161/01.HYP.0000121881.77212.b1 10.1017/S002966510800596X 10.1007/978-3-540-79088-4_11 10.1016/S0895-7061(01)02236-1 10.2165/00003495-200767070-00005 10.1111/j.1476-5381.2009.00187.x 10.1086/321276 10.1161/01.HYP.0000091371.53502.D3 10.1681/ASN.2006040368 10.1046/j.1523-1755.63.s84.24.x 10.5152/dir.2014.13513 10.1111/j.1476-5381.1985.tb11094.x 10.1038/ajh.2009.70 10.1291/hypres.30.503 10.1177/147323000603400308 10.2147/DMSO.S45183 10.1159/000313927 10.1038/nrneph.2010.152 10.2215/CJN.02560607 10.1111/1440-1681.12268 10.3892/ijmm_00000161 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media B.V., part of Springer Nature 2018 International Urology and Nephrology is a copyright of Springer, (2018). All Rights Reserved. |
Copyright_xml | – notice: Springer Science+Business Media B.V., part of Springer Nature 2018 – notice: International Urology and Nephrology is a copyright of Springer, (2018). All Rights Reserved. |
DBID | AAYXX CITATION NPM 3V. 7QP 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s11255-018-1812-2 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Academic Middle East (New) PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1573-2584 |
EndPage | 723 |
ExternalDocumentID | 29404926 10_1007_s11255_018_1812_2 |
Genre | Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 2.D 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5QI 5RE 5VS 67Z 6NX 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LLZTM M1P M4Y MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ NPM 7QP 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO |
ID | FETCH-LOGICAL-c2872-75a864e1e96c47609ae9a8e0c6cec2cd6ea8ec787f47a5e119ad2c6e97175fbd3 |
IEDL.DBID | U2A |
ISSN | 0301-1623 1573-2584 |
IngestDate | Thu Sep 04 16:36:59 EDT 2025 Sat Aug 16 06:21:02 EDT 2025 Mon Jul 21 05:49:51 EDT 2025 Tue Jul 01 01:24:07 EDT 2025 Thu Apr 24 23:04:52 EDT 2025 Fri Feb 21 02:35:44 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Type 2 diabetes Diabetic nephropathy β2-Adrenergic receptor Single nucleotide polymorphism Fatty acid binding protein-2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2872-75a864e1e96c47609ae9a8e0c6cec2cd6ea8ec787f47a5e119ad2c6e97175fbd3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-7370-7299 |
PMID | 29404926 |
PQID | 1994209276 |
PQPubID | 33540 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1995155283 proquest_journals_1994209276 pubmed_primary_29404926 crossref_citationtrail_10_1007_s11255_018_1812_2 crossref_primary_10_1007_s11255_018_1812_2 springer_journals_10_1007_s11255_018_1812_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20180400 |
PublicationDateYYYYMMDD | 2018-04-01 |
PublicationDate_xml | – month: 4 year: 2018 text: 20180400 |
PublicationDecade | 2010 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
PublicationTitle | International urology and nephrology |
PublicationTitleAbbrev | Int Urol Nephrol |
PublicationTitleAlternate | Int Urol Nephrol |
PublicationYear | 2018 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | Najafian, Mauer (CR32) 2012; 32 Weiss, Brown, Shuldiner, Hagberg (CR12) 2002; 10 Cakmak, Yağcı, Dursun, Herek, Fenkçi (CR19) 2014; 20 Masuo, Katsuya, Sugimoto, Kawaguchi, Rakugi, Ogihara, Tuck (CR11) 2007; 30 Kudat, Akkaya, Sozen, Salman, Demirel, Ozcan, Atilgan, Yilmaz, Guven (CR18) 2006; 34 Van Eenoo, Delbeke (CR21) 2010; 195 Wang, Zhang, Ma, Feng, Niu, Liu (CR20) 2014; 41 Esler, Rumantir, Wisener, Kaye, Lambert, Hasting (CR5) 2001; 14 Yoshida, Kato, Yokoi, Watanabe, Metoki, Yoshida, Satoh, Aoyagi, Nishigaki, Suzuki, Nozawa, Yamada (CR13) 2009; 23 Canani, Capp, Ng, Choo, Maia, Nabinger, Santos, Crispim, Roisemberg, Krolewski, Gross (CR9) 2005; 54 Nashar, Egan (CR26) 2014; 7 Dorn (CR24) 2010; 90 Atala, Goulart, Guerra, Mostarda, Rodrigues, Mello, Casarine, Irigoyen, Pereira, Consolim-Colombo (CR25) 2015; 7 Nakagawa, Tanabe, Croker, Johnson, Grant, Kosugi, Li (CR1) 2011; 7 Hall, Jones, Kuo, da Silva, Tallam, Liu (CR4) 2003; 5 Leineweber, Heusch (CR10) 2009; 58 Francis (CR23) 1988; 12 Masuo, Kawaguchi, Mikami, Ogihara, Tuck (CR16) 2003; 42 Göthert, Hentrich (CR22) 1985; 85 Chen, Lipkowitz, Salem, Fung, Bhatnagar, Mahata, Nievergelt, Rao, Mahata, Schork, Hicks, Bowden, Freedman, Brophy, O’Connor (CR8) 2010; 32 Wang, Karino, Yamasaki, Zhang, Masuda, Yamaguchi, Shiwaku, Nabika (CR15) 2009; 22 Ritchie, Hahn, Roodi, Bailey, Dupont, Parl, Moore (CR28) 2001; 69 Wang, Nabika, Notsu, Takabatake (CR30) 2008; 31 Marti, Martinez-González, Martinez (CR14) 2008; 67 Wang, Takabatake, Kobayashi, Nabika (CR31) 2008; 35 Lindner, Wanner, Berger (CR6) 2003; 63 Ma, Zuo, Chen, Luo, Yu, Li, Xu, Huang, Wang, Huang, Wang, Xu, Wang (CR17) 2006; 17 Masuo, Rakugi, Ogihara, Esler, Lambert (CR27) 2010; 6 Coccheri (CR2) 2007; 67 Joles, Koomans (CR3) 2004; 43 Sinski, Lewandowski, Abramczyk, Narkiewicz, Gaciong (CR29) 2006; 57 Freedman, Bostrom, Daeihagh, Bowden (CR7) 2007; 2 T Wang (1812_CR20) 2014; 41 T Yoshida (1812_CR13) 2009; 23 S Coccheri (1812_CR2) 2007; 67 D Lindner (1812_CR6) 2003; 63 LH Canani (1812_CR9) 2005; 54 T Wang (1812_CR15) 2009; 22 K Nashar (1812_CR26) 2014; 7 P Cakmak (1812_CR19) 2014; 20 T Nakagawa (1812_CR1) 2011; 7 B Najafian (1812_CR32) 2012; 32 YC Ma (1812_CR17) 2006; 17 MM Atala (1812_CR25) 2015; 7 K Masuo (1812_CR27) 2010; 6 K Masuo (1812_CR11) 2007; 30 H Kudat (1812_CR18) 2006; 34 Y Chen (1812_CR8) 2010; 32 M Göthert (1812_CR22) 1985; 85 T Wang (1812_CR30) 2008; 31 EP Weiss (1812_CR12) 2002; 10 M Esler (1812_CR5) 2001; 14 K Leineweber (1812_CR10) 2009; 58 T Wang (1812_CR31) 2008; 35 JA Joles (1812_CR3) 2004; 43 JE Hall (1812_CR4) 2003; 5 K Masuo (1812_CR16) 2003; 42 MD Ritchie (1812_CR28) 2001; 69 GS Francis (1812_CR23) 1988; 12 BI Freedman (1812_CR7) 2007; 2 P Eenoo Van (1812_CR21) 2010; 195 M Sinski (1812_CR29) 2006; 57 GW Dorn 2nd (1812_CR24) 2010; 90 A Marti (1812_CR14) 2008; 67 |
References_xml | – volume: 32 start-page: 415 issue: 5 year: 2012 end-page: 422 ident: CR32 article-title: Morphological features of declining renal function in type 1 diabetes publication-title: Semin Nephrol doi: 10.1016/j.semnephrol.2012.07.003 – volume: 6 start-page: 58 issue: 2 year: 2010 end-page: 67 ident: CR27 article-title: Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance publication-title: Curr Diabetes Rev doi: 10.2174/157339910790909396 – volume: 31 start-page: 561 issue: 3 year: 2008 end-page: 568 ident: CR30 article-title: Sympathetic regulation of renal functions in the SHRSP-based congenic rats for chromosome-1 blood pressure QTL publication-title: Hypertens Res doi: 10.1291/hypres.31.561 – volume: 54 start-page: 3326 issue: 11 year: 2005 end-page: 3330 ident: CR9 article-title: The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes publication-title: Diabetes doi: 10.2337/diabetes.54.11.3326 – volume: 10 start-page: 145 issue: 3 year: 2002 end-page: 157 ident: CR12 article-title: Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00070.2001 – volume: 5 start-page: 386 issue: 5 year: 2003 end-page: 392 ident: CR4 article-title: Impact of the obesity epidemic on hypertension and renal disease publication-title: Curr Hypertens Rep doi: 10.1007/s11906-003-0084-z – volume: 12 start-page: 250 issue: 1 year: 1988 end-page: 254 ident: CR23 article-title: Modulation of peripheral sympathetic nerve transmission publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(88)90382-8 – volume: 90 start-page: 1013 issue: 3 year: 2010 end-page: 1062 ident: CR24 article-title: Adrenergic signaling polymorphisms and their impact on cardiovascular disease publication-title: Physiol Rev doi: 10.1152/physrev.00001.2010 – volume: 35 start-page: 1365 issue: 11 year: 2008 end-page: 1370 ident: CR31 article-title: Sympathetic regulation of the renal functions in the reciprocal congenic rats for chromosome 1 blood pressure QTL publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/j.1440-1681.2008.04990.x – volume: 43 start-page: 699 issue: 4 year: 2004 end-page: 706 ident: CR3 article-title: Causes and consequences of increased sympathetic activity in renal disease publication-title: Hypertension doi: 10.1161/01.HYP.0000121881.77212.b1 – volume: 67 start-page: 1 issue: 1 year: 2008 end-page: 8 ident: CR14 article-title: Interaction between genes and lifestyle factors on obesity publication-title: Proc Nutr Soc doi: 10.1017/S002966510800596X – volume: 195 start-page: 227 year: 2010 end-page: 249 ident: CR21 article-title: Beta-adrenergic stimulation publication-title: Handb Exp Pharmacol doi: 10.1007/978-3-540-79088-4_11 – volume: 14 start-page: 304S issue: 11–2 year: 2001 end-page: 309S ident: CR5 article-title: Sympathetic nervous system and insulin resistance from obesity to diabetes publication-title: Am J Hyperten doi: 10.1016/S0895-7061(01)02236-1 – volume: 7 start-page: 153 issue: 1 year: 2015 end-page: 161 ident: CR25 article-title: Arg16Gly and Gln27Glu β2 adrenergic polymorphisms influence cardiac autonomic modulation and baroreflex sensitivity in healthy young Brazilians publication-title: Am J Transl Res – volume: 67 start-page: 997 issue: 7 year: 2007 end-page: 1026 ident: CR2 article-title: Approaches to prevention of cardiovascular complications and events in diabetes mellitus publication-title: Drugs doi: 10.2165/00003495-200767070-00005 – volume: 58 start-page: 61 issue: 1 year: 2009 end-page: 69 ident: CR10 article-title: β1- and β2-adrenoceptor polymorphisms and cardiovascular diseases publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2009.00187.x – volume: 69 start-page: 138 issue: 1 year: 2001 end-page: 147 ident: CR28 article-title: Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer publication-title: Am J Hum Genet doi: 10.1086/321276 – volume: 42 start-page: 474 issue: 4 year: 2003 end-page: 480 ident: CR16 article-title: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation publication-title: Hypertension doi: 10.1161/01.HYP.0000091371.53502.D3 – volume: 57 start-page: 79 issue: Suppl 11 year: 2006 end-page: 92 ident: CR29 article-title: Why study sympathetic nervous system? publication-title: J Physiol Pharmacol – volume: 17 start-page: 2927 year: 2006 end-page: 2944 ident: CR17 article-title: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006040368 – volume: 63 start-page: S186 issue: 84 year: 2003 end-page: S1913 ident: CR6 article-title: Genetic aspects of diabetic nephropathy publication-title: Kidney Int Suppl doi: 10.1046/j.1523-1755.63.s84.24.x – volume: 20 start-page: 374 issue: 5 year: 2014 end-page: 378 ident: CR19 article-title: Renal diffusion-weighted imaging in diabetic nephropathy: correlation with clinical stages of disease publication-title: Diagn Interv Radiol doi: 10.5152/dir.2014.13513 – volume: 85 start-page: 933 issue: 4 year: 1985 end-page: 941 ident: CR22 article-title: Identification of presynaptic beta 2-adrenoceptors on the sympathetic nerve fibres of the human pulmonary artery publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1985.tb11094.x – volume: 22 start-page: 742 issue: 7 year: 2009 end-page: 747 ident: CR15 article-title: Effects of G994T in the Lp-PLA gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese—the Shimane Study publication-title: Am J Hypertens doi: 10.1038/ajh.2009.70 – volume: 30 start-page: 503 issue: 6 year: 2007 end-page: 511 ident: CR11 article-title: High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals publication-title: Hypertens Res doi: 10.1291/hypres.30.503 – volume: 23 start-page: 529 issue: 4 year: 2009 end-page: 537 ident: CR13 article-title: Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus publication-title: Int J Mol Med – volume: 34 start-page: 291 issue: 3 year: 2006 end-page: 296 ident: CR18 article-title: Heart rate variability in diabetes patients publication-title: J Int Med Res doi: 10.1177/147323000603400308 – volume: 41 start-page: 657 issue: 9 year: 2014 end-page: 662 ident: CR20 article-title: Additive effect of polymorphisms in the β2-adrenoceptor and NADPH oxidase p22phox genes contributes to the loss of estimated glomerular filtration rate in Chinese publication-title: Clin Exp Pharmacol Physiol – volume: 7 start-page: 421 year: 2014 end-page: 435 ident: CR26 article-title: Relationship between chronic kidney disease and metabolic syndrome: current perspectives publication-title: Diabetes Metab Syndr Obes doi: 10.2147/DMSO.S45183 – volume: 32 start-page: 23 issue: 1 year: 2010 end-page: 30 ident: CR8 article-title: Progression of chronic kidney disease: adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis publication-title: Am J Nephrol doi: 10.1159/000313927 – volume: 7 start-page: 36 issue: 1 year: 2011 end-page: 44 ident: CR1 article-title: Endothelial dysfunction as a potential contributor in diabetic nephropathy publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2010.152 – volume: 2 start-page: 1306 issue: 6 year: 2007 end-page: 1316 ident: CR7 article-title: Genetic factors in diabetic nephropathy publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.02560607 – volume: 67 start-page: 997 issue: 7 year: 2007 ident: 1812_CR2 publication-title: Drugs doi: 10.2165/00003495-200767070-00005 – volume: 17 start-page: 2927 year: 2006 ident: 1812_CR17 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006040368 – volume: 5 start-page: 386 issue: 5 year: 2003 ident: 1812_CR4 publication-title: Curr Hypertens Rep doi: 10.1007/s11906-003-0084-z – volume: 14 start-page: 304S issue: 11–2 year: 2001 ident: 1812_CR5 publication-title: Am J Hyperten doi: 10.1016/S0895-7061(01)02236-1 – volume: 90 start-page: 1013 issue: 3 year: 2010 ident: 1812_CR24 publication-title: Physiol Rev doi: 10.1152/physrev.00001.2010 – volume: 42 start-page: 474 issue: 4 year: 2003 ident: 1812_CR16 publication-title: Hypertension doi: 10.1161/01.HYP.0000091371.53502.D3 – volume: 20 start-page: 374 issue: 5 year: 2014 ident: 1812_CR19 publication-title: Diagn Interv Radiol doi: 10.5152/dir.2014.13513 – volume: 63 start-page: S186 issue: 84 year: 2003 ident: 1812_CR6 publication-title: Kidney Int Suppl doi: 10.1046/j.1523-1755.63.s84.24.x – volume: 2 start-page: 1306 issue: 6 year: 2007 ident: 1812_CR7 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.02560607 – volume: 10 start-page: 145 issue: 3 year: 2002 ident: 1812_CR12 publication-title: Physiol Genomics doi: 10.1152/physiolgenomics.00070.2001 – volume: 57 start-page: 79 issue: Suppl 11 year: 2006 ident: 1812_CR29 publication-title: J Physiol Pharmacol – volume: 58 start-page: 61 issue: 1 year: 2009 ident: 1812_CR10 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2009.00187.x – volume: 41 start-page: 657 issue: 9 year: 2014 ident: 1812_CR20 publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/1440-1681.12268 – volume: 7 start-page: 421 year: 2014 ident: 1812_CR26 publication-title: Diabetes Metab Syndr Obes doi: 10.2147/DMSO.S45183 – volume: 195 start-page: 227 year: 2010 ident: 1812_CR21 publication-title: Handb Exp Pharmacol doi: 10.1007/978-3-540-79088-4_11 – volume: 7 start-page: 36 issue: 1 year: 2011 ident: 1812_CR1 publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2010.152 – volume: 43 start-page: 699 issue: 4 year: 2004 ident: 1812_CR3 publication-title: Hypertension doi: 10.1161/01.HYP.0000121881.77212.b1 – volume: 85 start-page: 933 issue: 4 year: 1985 ident: 1812_CR22 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1985.tb11094.x – volume: 7 start-page: 153 issue: 1 year: 2015 ident: 1812_CR25 publication-title: Am J Transl Res – volume: 23 start-page: 529 issue: 4 year: 2009 ident: 1812_CR13 publication-title: Int J Mol Med doi: 10.3892/ijmm_00000161 – volume: 12 start-page: 250 issue: 1 year: 1988 ident: 1812_CR23 publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(88)90382-8 – volume: 35 start-page: 1365 issue: 11 year: 2008 ident: 1812_CR31 publication-title: Clin Exp Pharmacol Physiol doi: 10.1111/j.1440-1681.2008.04990.x – volume: 31 start-page: 561 issue: 3 year: 2008 ident: 1812_CR30 publication-title: Hypertens Res doi: 10.1291/hypres.31.561 – volume: 69 start-page: 138 issue: 1 year: 2001 ident: 1812_CR28 publication-title: Am J Hum Genet doi: 10.1086/321276 – volume: 6 start-page: 58 issue: 2 year: 2010 ident: 1812_CR27 publication-title: Curr Diabetes Rev doi: 10.2174/157339910790909396 – volume: 30 start-page: 503 issue: 6 year: 2007 ident: 1812_CR11 publication-title: Hypertens Res doi: 10.1291/hypres.30.503 – volume: 22 start-page: 742 issue: 7 year: 2009 ident: 1812_CR15 publication-title: Am J Hypertens doi: 10.1038/ajh.2009.70 – volume: 32 start-page: 23 issue: 1 year: 2010 ident: 1812_CR8 publication-title: Am J Nephrol doi: 10.1159/000313927 – volume: 67 start-page: 1 issue: 1 year: 2008 ident: 1812_CR14 publication-title: Proc Nutr Soc doi: 10.1017/S002966510800596X – volume: 54 start-page: 3326 issue: 11 year: 2005 ident: 1812_CR9 publication-title: Diabetes doi: 10.2337/diabetes.54.11.3326 – volume: 34 start-page: 291 issue: 3 year: 2006 ident: 1812_CR18 publication-title: J Int Med Res doi: 10.1177/147323000603400308 – volume: 32 start-page: 415 issue: 5 year: 2012 ident: 1812_CR32 publication-title: Semin Nephrol doi: 10.1016/j.semnephrol.2012.07.003 |
SSID | ssj0009800 |
Score | 2.1673837 |
Snippet | Purpose
Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the... Since altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the effect... PurposeSince altered sympathetic nerve activity and insulin resistance are implicated in the pathogenesis of type 2 diabetic nephropathy, we investigated the... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 715 |
SubjectTerms | Adrenergic receptors Diabetes Diabetes mellitus Diabetic nephropathy Diffusion coefficient Epidermal growth factor receptors Fatty acid-binding protein Fatty acids Gene polymorphism Genetic analysis Genotypes Glomerular filtration rate Heart rate High-performance liquid chromatography Homozygotes Insulin Insulin resistance Magnetic resonance imaging Mass spectroscopy Medicine Medicine & Public Health Metabolic disorders Nephrology Nephrology - Original Paper Nephropathy Norepinephrine Urology |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagSIgLovwGChokTqCI4DjO5oSqiqpCKheotLfIa09QpGy83WwP-1oceQieiRnH2QVV7XEVZ9bSfPGM5-cbId6hmhUS8yJl8rJUkRFJmRIlRdSLyhYKteZu5PNv-uxCfZ0X8xhwG2JZ5XQmhoPaecsx8o_MYSuzSpb68-oy5alRnF2NIzTuinuBuozwXM7LPenubGxBIRDTXmQ-ZTVD6xxZdi5bozsU2bhU_m-Xrjmb1xKlwf6cPhIPo-MIx6OmD8Ud7B-L--cxNf5E_P6-5Ta-wLtM68Z-BfANkIcHf35JMNyz7bmKxa_B9A4as9lsaWHrYNGG5hYIrA1tDxJWvtsuPSmhHZYDkCQW09HOWeTPzi9xzQWs0LRdJN4FJp0AeplHcuOAEClbB-BYL3Csl-SOsd7WQo8rntBADuj2qbg4_fLj5CyNgxlSSxcs8sgLM9MKP2GlrSp1xgTfZoaZ1RattE4j_bJ0FDSqNAWSaoyTVmNFd8eiWbj8mTjofY8vBDR5QwDJbeOcU6ZQhpCipMGmklZZrBKRTWqpbWQt5-EZXb3nW2ZN1qTJmjVZy0S8372yGik7blt8NOm6jl_vUO-xloi3u8f03XEyxfTor8Iano5D3lkino8Y2f2brFTGRIyJ-DCB5h_hN23l5e1beSUeSIZrqBo6Egeb9RW-Jodos3gTUP8XJKIJww priority: 102 providerName: ProQuest |
Title | Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy |
URI | https://link.springer.com/article/10.1007/s11255-018-1812-2 https://www.ncbi.nlm.nih.gov/pubmed/29404926 https://www.proquest.com/docview/1994209276 https://www.proquest.com/docview/1995155283 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fi9NAEF_0DsQX8b_Rs4zgkxJIN7ub5rFKz0O5Q9RCfQrbzewRSJPS9B76tXz0Q_iZnMmfVjkVfCqhk8mSmcnM7sz8RoiXqCZaYqxDBi8LFTmRkCFRQkSzTJ1WaAx3I59fmLO5er_Qi76Puxmq3YeUZPulPjS7kS_mQjPa9ZBXCum7e6xp687WOJfTA9LupOs7Ic2lBch4SGX-icXvzuhahHktO9o6ndO74k4fLcK0E-89cQOr--LWeZ8PfyC-f95x714Ltkx0XZMC1B4orIMf3yRYbtSuuXSl3oCtcvB2u90RYZHDsmg7WqCFaigqkLCuy92qpjdfNKsGiBOzKWnlzPKyrFe44apV8EXZo-0CI00A3cxzuLFB6HFaG-ADXuADXuLbHfAWDipc81gGijp3D8X8dPbl7VnYT2MIHe2qKAzXdmIUjjE1TiUmYlRvO8HIGYdOutwgXTmyf68Sq3E8Tm0uncGUNozaL_P4kTiq6gqfCPCxJ62Inc_zXFmtLKmHkhZ9Kp1ymAYiGsSSuR6qnCdmlNkBZJklmZEkM5ZkJgPxan_LusPp-BfxySDrrDfZJmOQZBmlMjGBeLH_m4yNMyi2wvqqpeGROBSSBeJxpyP7p8lURYy-GIjXg9L8wvxvS3n6X9TPxG3J2ttWDp2Io-3mCp9TULRdjsTNZJGMxPH03dcPM_p9M7v4-GnUmsZP5XsKPQ |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAIuiDeBAoMEF5CFs1lv4gNCPFqltIkQtFJvZrMeI0uOHeJUKH-KA0d-BL-JGT8SUEVvPVreHa81s7uzO_N9A_CU9DBQ1A88IS_zNG8inlCieERmGrpAkzGCRh5PzOhYfzgJTrbgR4uFkbTKdk2sFuq4cHJH_lI4bJUfqoF5Pf_mSdUoia62JTRqszig1Xc-spWv9t-zfp8ptbd79G7kNVUFPMenA3YnAzs0mnoUGqcHxhd2ajsk3xlHTrnYED85tuNED2xAvV5oY-UMhXzwCZJp3Ge5l2BbC6K1A9tvdycfP21ofoc16IWnDf-96rdx1Aqsx76EJMrxqY13VU_9uxOecW_PhGarHW_vOlxrXFV8U9vWDdii_CZcHjfB-Fvw6_NKgIMV0zO3qxESWCTIPiX-_qnQCkq8kLyZYoE2jzGxy-WKG6YxTtMKToMVT0Sao8J5ka1mBas9LWclsiQRk_HIReTXrJjRQlJmMUmzhuoXheYCubMUAaeSsCGJLVFul1Ful1lufbucOsxpLjUh2OVd3YbjC1HaHejkRU73AJN-wibZd0kcx9oG2rJtamUpCZXTjsIu-K1aItfwpEu5jizaMDyLJiPWZCSajFQXnq-7zGuSkPMa77S6jpr1oow21t2FJ-vXPNMlfGNzKk6rNlKPh_3BLtytbWT9NRVqX6gfu_CiNZq_hP9vKPfPH8pjuDI6Gh9Gh_uTgwdwVYnpVjlLO9BZLk7pIbtjy-mjZg4gfLnoafcHQbxJIg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkSouiH8CBQYJLqCoWcdxNgeEEGXVUlohQaW9Ba8zRpGyybLZCuW1OPYheCZm8rMLquitx2idibXzjT32zHwjxAtU40hiGPlMXuYr2kR8pkTxEfUssZFCrbka-fhEH5yqj9NouiXOh1oYTqsc1sR2oc4qy3fke8xhK4NExnrP9WkRn_cnbxc_fO4gxZHWoZ1GB5EjbH7S8a1-c7hPun4p5eTD1_cHft9hwLd0UiDXMjJjrXCEibYq1gEzVZsxBlZbtNJmGunJEqadik2Eo1FiMmk1JnQIitwsC0nuNXE9DsmrIluKp_GG8Hfclb-QAdH_IMMhotqW7ZFXwSlzdH6j_dWX_-6JFxzdC0Hadu-b3BI3e6cV3nUouy22sLwjdo77sPxdcf6l4RLClvOZxnW1ElA5IO8Sfv-SYLhevOIMmmoJpszAmdWqoYF5BrO8LayBljEiL0HCoiqaeUUAyOt5DSSJxRQ0cxb5vajmuOTkWXB50ZP-AhNeAL3M7cCxRujpYmvge2bge2aS290z5xZKXHB3CHJ-m3vi9EpUdl9sl1WJDwW40BE4Q-uyLFMmUoZQqqRBl0irLCaeCAa1pLZnTOfGHUW64XpmTaakyZQ1mUpPvFq_sujoQi4bvDvoOu1Xjjrd4NwTz9c_k81zIMeUWJ21Y7gzD3mGnnjQYWT9NZmogEkgPfF6AM1fwv83lUeXT-WZ2CFjSz8dnhw9FjckI7dNXtoV26vlGT4hv2w1e9oaAIhvV21xfwC56kvp |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synergistical+action+of+the+%CE%B22+adrenoceptor+and+fatty+acid+binding+protein+2+polymorphisms+on+the+loss+of+glomerular+filtration+rate+in+Chinese+patients+with+type+2+diabetic+nephropathy&rft.jtitle=International+urology+and+nephrology&rft.au=Wang%2C+Tao&rft.au=Zhang%2C+Yan&rft.au=Wang%2C+Ning&rft.au=Liu%2C+Qiong&rft.date=2018-04-01&rft.eissn=1573-2584&rft_id=info:doi/10.1007%2Fs11255-018-1812-2&rft_id=info%3Apmid%2F29404926&rft.externalDocID=29404926 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-1623&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-1623&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-1623&client=summon |